Literature DB >> 24583011

Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.

Jasmin Strotmeier1, Stefan Mahrhold2, Nadja Krez1, Constantin Janzen1, Jianlong Lou3, James D Marks3, Thomas Binz4, Andreas Rummel5.   

Abstract

Botulinum neurotoxins (BoNTs) inhibit neurotransmitter release by hydrolysing SNARE proteins. The most important serotype BoNT/A employs the synaptic vesicle glycoprotein 2 (SV2) isoforms A-C as neuronal receptors. Here, we identified their binding site by blocking SV2 interaction using monoclonal antibodies with characterised epitopes within the cell binding domain (HC). The site is located on the backside of the conserved ganglioside binding pocket at the interface of the HCC and HCN subdomains. The dimension of the binding pocket was characterised in detail by site directed mutagenesis allowing the development of potent inhibitors as well as modifying receptor binding properties.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Botulinum neurotoxin A; Monoclonal antibody; Neutralisation; Protein receptor binding site; SV2

Mesh:

Substances:

Year:  2014        PMID: 24583011      PMCID: PMC4067265          DOI: 10.1016/j.febslet.2014.02.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.

Authors:  B P Mullaney; M G Pallavicini; J D Marks
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization.

Authors:  Thomas Binz; Steffen Bade; Andreas Rummel; Astrid Kollewe; Jürgen Alves
Journal:  Biochemistry       Date:  2002-02-12       Impact factor: 3.162

3.  SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family.

Authors:  R Janz; T C Südhof
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

4.  Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures.

Authors:  H Kawai; M L Allende; R Wada; M Kono; K Sango; C Deng; T Miyakawa; J N Crawley; N Werth; U Bierfreund; K Sandhoff; R L Proia
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

5.  Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity.

Authors:  Andreas Rummel; Steffen Bade; Jürgen Alves; Hans Bigalke; Thomas Binz
Journal:  J Mol Biol       Date:  2003-02-21       Impact factor: 5.469

6.  Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Authors:  A Nowakowski; C Wang; D B Powers; P Amersdorfer; T J Smith; V A Montgomery; R Sheridan; R Blake; L A Smith; J D Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

7.  The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.

Authors:  Andreas Rummel; Stefan Mahrhold; Hans Bigalke; Thomas Binz
Journal:  Mol Microbiol       Date:  2004-02       Impact factor: 3.501

8.  Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Authors:  Ronnie Per-Arne Berntsson; Lisheng Peng; Linda Marie Svensson; Min Dong; Pål Stenmark
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

9.  Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.

Authors:  Roger M Benoit; Daniel Frey; Manuel Hilbert; Josta T Kevenaar; Mara M Wieser; Christian U Stirnimann; David McMillan; Tom Ceska; Florence Lebon; Rolf Jaussi; Michel O Steinmetz; Gebhard F X Schertler; Casper C Hoogenraad; Guido Capitani; Richard A Kammerer
Journal:  Nature       Date:  2013-11-17       Impact factor: 49.962

10.  Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.

Authors:  Min Dong; David A Richards; Michael C Goodnough; William H Tepp; Eric A Johnson; Edwin R Chapman
Journal:  J Cell Biol       Date:  2003-09-22       Impact factor: 10.539

View more
  23 in total

1.  Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.

Authors:  Abby R Kroken; Faith C Blum; Madison Zuverink; Joseph T Barbieri
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

2.  SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons.

Authors:  Erkan Kiris; James C Burnett; Jonathan E Nuss; Laura M Wanner; Brian D Peyser; Hao T Du; Glenn Y Gomba; Krishna P Kota; Rekha G Panchal; Rick Gussio; Christopher D Kane; Lino Tessarollo; Sina Bavari
Journal:  Neurotox Res       Date:  2015-03-18       Impact factor: 3.911

Review 3.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

Authors:  Kwok-Ho Lam; Guorui Yao; Rongsheng Jin
Journal:  Prog Biophys Mol Biol       Date:  2015-02-19       Impact factor: 3.667

4.  Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations.

Authors:  Sabine Pellett; William H Tepp; Eric A Johnson
Journal:  FEBS Lett       Date:  2019-07-04       Impact factor: 4.124

5.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

6.  Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines.

Authors:  C Bandala; A L Cortés-Algara; C M Mejía-Barradas; I Ilizaliturri-Flores; R Dominguez-Rubio; C I Bazán-Méndez; E Floriano-Sánchez; J P Luna-Arias; M Anaya-Ruiz; E Lara-Padilla
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

Review 8.  Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.

Authors:  Dong-Wan Kim; Sun-Kyung Lee; Joohong Ahnn
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

Review 9.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

10.  Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

Authors:  Skadi Kull; K Melanie Schulz; Jasmin Weisemann; Sebastian Kirchner; Tanja Schreiber; Alexander Bollenbach; P Wojtek Dabrowski; Andreas Nitsche; Suzanne R Kalb; Martin B Dorner; John R Barr; Andreas Rummel; Brigitte G Dorner
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.